Technological foresight and technological scanning for identifying priorities and opportunities: the biotechnology and health sector

A Antunes, C Canongia - foresight, 2006 - emerald.com
Purpose–This paper aims to present a methodology for technological foresight and
technological scanning based on S&T and knowledge indicators. Design/methodology …

Biotechnology: the emerging battlefield for US and Japanese pharmaceutical companies

A Wiexndt, N Amin - Technology Analysis & Strategic Management, 1994 - Taylor & Francis
The Japanese pharmaceutical industry has lagged behind the US in developing and
marhting innovative new compounh. A gap anabsis rebing on international publication and …

Technology Opportunities: Evaluating the Idea

C Shimasaki - Biotechnology Entrepreneurship, 2020 - Elsevier
All biotechnology products originate from underlying technology research and product
concepts that are based upon novel science. In reality, there is no shortage of product ideas …

[HTML][HTML] Critical success factors for biotechnology industry in Canada

S Vanderbyl, S Kobelak - Journal of Commercial Biotechnology, 2007 - Springer
Critical success factors and performance indicators provide the biotechnology industry with
a foundation on which to grow and manage risks. In a recent survey of 247 biotechnology …

The boston bio-bang: The emergence of a “Regional system of innovation”

H Van der Voort, M De Jong - Knowledge, Technology & Policy, 2004 - Springer
In this article we will describe the emergence of a great number of small, regionally
concentrated, innovative biotech companies. We see these organizations as “hosts” of …

Roadmapping—agent of change

A McMillan - Research-Technology Management, 2003 - Taylor & Francis
Eight years ago, Rockwell Automation began a journey, detailed in this article, to redefine
and enhance its technology management processes. The goal was to enable better …

Risk and return in the biotech industry

H Bruneo, E Giacomini, G Iannotta, A Murthy… - International Journal of …, 2024 - emerald.com
Purpose Biotech companies stand as key actors in pharmaceutical innovation. The high risk
and long timelines inherent with their R&D investments might hinder their access to funding …

Building and leveraging the innovation ecosystem and clusters: universities, startups, accelerators, alliances, and partnerships: A “From the Boardroom” Perspective …

A Boni, M Gunn - Journal of Commercial …, 2021 - commercialbiotechnology.com
We examine and analyze the elements important for developing a commercialization
strategy for an emerging technology of great relevance to biopharma: three-dimensional bio …

Technology roadmap for the development of a 3D cell culture workstation for a biomedical industry startup

AG Ramos, T Daim, L Gaats, DW Hutmacher… - … Forecasting and Social …, 2022 - Elsevier
This paper is a first attempt to establish how technology roadmapping, commonly reserved
for established organizations, can be adapted for the characteristics and limitations of a …

The business of commercialization and innovation

AA Boni - Journal of Commercial Biotechnology, 2018 - search.proquest.com
We focus on the processes and strategies utilized by entrepreneurs to commercialize new
technologies, thereby creating significant change and value in new, or existing markets, ie …